Retraction

MicroRNA‑10b suppresses the migration and invasion of chondrosarcoma cells by targeting brain‑derived neurotrophic factor

Paper Information

Record ID:
29425
Publication Date:
November 05, 2015
Retraction Date:
June 08, 2021 (4.5 years years ago)
Article Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Citations (11)

11
Total Citations
5
Post-Retraction
(45.5%)
6
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
3 After 2+ years
1077 Days since retraction (latest)
BDNF Modulation by microRNAs: An Update on the Experimental Evidence
Gilmara Gomes de Assis, Eugenia Murawska‐Ciałowicz
Cells Open Access
Published: May 2024
5 citations
1077 days after retraction
BDNF Modulation by microRNAs: An Update on the Experimental Evidence
Gilmara Gomes de Assis, Eugenia Murawska‐Ciałowicz
Unknown Journal Open Access
Published: Apr 2024
1029 days after retraction
Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1
Ling Xiao, Hui Zhou, Xiangping Li et al. (11 authors)
Oncotarget Open Access
Published: Jan 2024
942 days after retraction
BDNF and its signaling in cancer
Mohammad Malekan, Sasan Salehi Nezamabadi, Elham Samami et al. (6 authors)
Journal of Cancer Research and Clinical Oncology
Published: Sep 2022
35 citations
478 days after retraction
A literature Review: The genomic landscape of spinal chondrosarcoma and potential diagnostic, prognostic & therapeutic implications
Mohmmed Elmajee, Khabab Osman, Alexander Dermanis et al. (6 authors)
Interdisciplinary Neurosurgery
Published: Aug 2022
1 citation
441 days after retraction
An update on current and future treatment options for chondrosarcoma
Iona MacDonald, Chih‐Yang Lin, Shu‐Jui Kuo et al. (5 authors)
Expert Review of Anticancer Therapy
Published: Aug 2019
55 citations
649 days before retraction
Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells
Chih‐Yang Lin, Shih‐Wei Wang, Yen‐Ling Chen et al. (12 authors)
Cell Death and Disease Open Access
Published: Aug 2017
49 citations
1405 days before retraction
Therapeutic applications of histone deacetylase inhibitors in sarcoma
Fan Tang, Edwin Choy, Chongqi Tu et al. (5 authors)
Cancer Treatment Reviews Open Access
Published: Jul 2017
62 citations
1433 days before retraction
Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma
Yohei Kitamura, Hikaru Sasaki, Kazunari Yoshida
Brain Tumor Pathology
Published: Apr 2017
22 citations
1529 days before retraction
MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma
Feifei Pu, Fengxia Chen, Zengwu Shao
Tumor Biology
Published: Oct 2016
13 citations
1701 days before retraction
Up‐regulation of mir‐10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer
Hongwei� Jiang, Jijun Liu, Yingtao Chen et al. (6 authors)
Cancer Medicine Open Access
Published: Sep 2016
35 citations
1738 days before retraction
Quick Stats
Total Citations: 11
Years Since Retraction: 4.5 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
AKR1C1 alleviates LPS-induced ALI in mice by activating the…
Molecular Medicine Reports • 13 citations
Tan IIA inhibits H1299 cell viability through the MDM4-IAP3…
Molecular Medicine Reports • 17 citations
Tanshinone IIA improves hypoxic ischemic encephalopathy thr…
Molecular Medicine Reports • 26 citations
NG25, an inhibitor of transforming growth factor-β-activate…
Molecular Medicine Reports • 10 citations
Limb remote ischemic post-conditioning reduces injury and i…
Molecular Medicine Reports • 18 citations